Business
Grant of share options to Dir
Grant of share options to Dir.
About this update from Gunsynd Plc
[{"type":"text","content":"\n RNS Number : 3036X Syntopix Group plc 03 December 2010 \n \n\n \n \n\n\n\n\nPress Release\n\n\n03 December 2010\n\n\n\n\n \nSyntopix Group plc\n(\"Syntopix\" or \"the Company\")\n \nGrant of share options to Directors\n \nSyntopix Group plc (AIM: SYN), the speciality research group focused on topical antimicrobial innovations for products in the medicinal and consumer healthcare markets announces that on 2 December 2010, a total of 123,790 options over the Company's ordinary shares were granted to Directors pursuant to the Syntopix Executive Share Option Scheme (the \"ESO Scheme\"). In addition, a further 38,095 options over the Company's ordinary shares were granted to IP Group plc (\"IP Group\") in respect of the provision by IP Group of the services of Mike Townend to serve as a non-executive Director of Syntopix. These options were granted in place of Directors' fees waived by IP Group. Mr Townend has no beneficial interest in the options granted.\n \nThe options were granted for nil consideration with an exercise price of 52.5 pence per share and are exercisable after 12 months from the date of grant. There are no performance conditions attached to these share options other than the Directors concerned must be still in position in order for the options to vest. The options have been granted in exchange for the waiver of Directors' fees for a further period of 12 months by each of the Directors who have been granted options.\n \nAs a result of these options being granted, the interests of these Directors in options are as follows:\n \n\n\n\n\nName of Director\n\n\nOptions granted\n\n\nTotal options\n\n\nESO scheme\n\n\n\n\nTom Bannatyne\n\n\n47,600\n\n\n47,600\n\n\n47,600\n\n\n\n\nGwyn Humphreys\n\n\n38,095\n\n\n64,762\n\n\n64,762\n\n\n\n\nDarren Bamforth\n\n\n38,095\n\n\n114,627\n\n\n114,627\n\n\n\n\n\n \nSave for the above, the Directors beneficial interests remain unchanged and as previously announced.\n- Ends -\n \nFor further information, please contact:\n \n\n\n\n\nSyntopix Group plc\n\n\n\n\n\n\n\nDr Stephen Jones, Chief Executive Officer\n\n\n+44 (0)845 125 9204\n\n\n\n\n\n\n\nwww.syntopix.com\n\n\n\n\n \n\n\n\n\nZeus Capital Ltd\n\n\n\n\n\n\n\nAlex Clarkson\n\n\nTel: +44(0)161 831 1512 \n\n\n\n\n\n\n\nwww.zeuscapital.c...